C4 Therapeutics (CCCC) Receivables (2019 - 2026)
C4 Therapeutics' Receivables was $1.33 million in Q2 2026, down 38.2% from $2.16 million a year earlier and down 53.7% from the prior quarter.
Powered by 
Analysis
C4 Therapeutics (CCCC) Receivables (2019 - 2026) Analysis & Trends
At the end of FY2025, Receivables at C4 Therapeutics came in at $2.4 million, down 22.6% from FY2024.
- Receivables shows a five-year compound annual growth rate of -11.7% (FY2020 to FY2025).
- In earlier years, Receivables was $3.1 million in FY2024 (-73.7%), $11.8 million in FY2023 (+701.0%), $1.47 million in FY2022 (-74.2%) and $5.72 million in FY2021 (+27.5%).
- The Q2 2026 figure marks the lowest quarterly Receivables since Q2 2024.
- Compared with a year earlier, Receivables has declined for four straight quarters, with an average decline of 27.3% over the last seven quarters.
- The best year-over-year quarter for Receivables over five years was Q4 2023 (growth of 701.0%); the worst was Q4 2022 (a decline of 74.2%).
- Per Business Quant data, CCCC's Receivables in the three quarters before Q2 2026 was $2.88 million (Q1 2026), $2.4 million (Q4 2025) and $6.54 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | C4 Therapeutics | 383.47 Mn | -546.29 Mn | - | 1.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.33 Mn |
| Mar 31, 2026 | 2.88 Mn |
| Dec 31, 2025 | 2.40 Mn |
| Sep 30, 2025 | 6.54 Mn |
| Jun 30, 2025 | 2.16 Mn |
| Mar 31, 2025 | 8.03 Mn |
| Dec 31, 2024 | 3.10 Mn |
| Sep 30, 2024 | 10.34 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 13.60 Mn |
| Dec 31, 2023 | 11.80 Mn |
| Sep 30, 2023 | 500,000.00 |
| Jun 30, 2023 | 1.03 Mn |
| Mar 31, 2023 | 528,000.00 |
| Dec 31, 2022 | 1.47 Mn |
| Sep 30, 2022 | 1.49 Mn |
| Jun 30, 2022 | 1.71 Mn |
| Mar 31, 2022 | 1.77 Mn |
| Dec 31, 2021 | 5.72 Mn |
| Sep 30, 2021 | 4.85 Mn |
API Access
C4 Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=CCCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "CCCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=CCCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();